Web Results

Antiepileptic Drugs and Markers of Vascular Risk - NCBI - National ...


Carla LoPinto-Khoury, MD and Scott Mintzer, MD<sup>*</sup> ..... Castro-Gago M, Novo- Rodriguez MI, Blanco-Barca MO, et al. ... Aggarwal A, Singh V, Batra S, et al. ... Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, ...

JAMA Network | JAMA Internal Medicine | Sodium and Potassium ...


Jul 11, 2011 ... Quanhe Yang, PhD; Tiebin Liu, MSPH; Elena V. Kuklina, MD, PhD; W. Dana ... Dowling, and Khoury, Mr Liu, and Ms Chang) and Division for Heart Disease ..... Cook NR, Obarzanek E, Cutler JA, et al; Trials of Hypertension ...

Management of 219 Consecutive Cases of Postcatheterization ...


ment with a compression bandage (89% vs. 76%, p. 0.04). ..... Cox GS, Young JR , Gray BR, Grubb MW, Hertzer NR. ... Kresowik TE, Khoury MD, Miller MV, et al.

Effects of Pretransplantation Treatment With Rituximab on Outcomes ...


Nov 15, 2004 ... Address reprint requests to Hanna Khoury, MD, FACP, Emory University .... There were no differences in the prevalence of bacteremia (R v NR groups, .... Flohr T, Hess G, Kolbe K, et al: Rituximab in vivo purging is safe and ...

The Scientific Foundation for Personal Genomics ...


Muin J. Khoury, MD, PhD, Office of Public Health Genomics, Centers for. Disease .... chronic diseases and are elaborated on by Miller et al.11. Khoury et al.

Interview: Dr. Muin J. Khoury Discusses the Future of Public Health ...


Aug 27, 2014 ... Muin J. Khoury, MD, PhD is the first and current director of the Office of Public Health Genomics at the Centers for Disease Control and ..... It takes a population perspective to the ... sion of this framework to the 10 essential public health serv- .... discovery research but much less on research that allows.

References: Endometrial cancer detailed guide


Feb 29, 2016 ... Abu-Rustum NR, Khoury-Collado F, Pandit-Taskar N, et al. ... Bethesda, MD, http: //seer.cancer.gov/csr/1975_2011/, based on November 2013 ...

Long-term (three-year) prognosis of patients treated with reperfusion ...


Shmuel Gottlieb, MD<sup>,, ,</sup> ,; Valentina Boyko, MSc,; David Harpaz, MD,; Hanoch Hod, MD, FACC,; Miriam Cohen, BSc,; Lori Mandelzweig, MPH,; Zahi Khoury, MD ,; Shlomo Stern, .... Women were treated with ART less frequently than men (39% vs. ...... 11; S Gottlieb, V Boyko, D Zahger, Israeli Thrombolytic Survey Group, et al .

Closed spinal dysraphism: Clinical manifestations, diagnosis, and ...


Oct 7, 2015 ... Chaouki Khoury, MD, MS ..... Tavafoghi V, Ghandchi A, Hambrick GW Jr, Udverhelyi GB. Cutaneous ... Golonka NR, Haga LJ, Keating RP, et al.

Kohrt, Brandon | Duke Global Health Institute


Dr. Kohrt has contributed to numerous documentary films including ... Kaiser BN, Kohrt BA, Keys HM, Khoury NM, Hagaman AK, McLean KE, ... Kohrt, B. A., Jordans, M. J. D., Rai, S., Shrestha, P., Luitel, N. P., Ramaiya, M K, Singla, D R. Patel, V. (2015). .... Kohrt BA, Jordans MJD, Tol WA, Speckman RA, Maharjan SM , et al.

Find Health Information on Healthline
Find Info About:
Healthline is the leading provider of health information.
More Info

Family History and Improving Health


Aug 26, 2009 ... Muin J. Khoury, M.D., Ph.D. ... Siobhan M. Dolan, M.D., M.P.H.; Family History and Those ... V. What Are the Factors That Encourage or Discourage Obtaining and Using a Family History? ..... Yoon PW, Scheuner MT, Peterson-Oehlke KL, et al. .... Bindraban NR, Van Valkengoed IGM, Mairuhu G, et al.

Get PDF (172K) - Wiley Online Library


Apr 1, 2009 ... Corresponding author: Hanna Jean Khoury, MD, Department of Hematology and Medical Oncology, Winship Cancer Institute, .... vs 16%; P ¼ .004) and major molecular response (16% vs ... NR. 15.2. 15. 14.1. 3.4. 3.4. 3.0. Median duration of therapy, mo ... Practical Considerations for Dasatinib/Khoury et al.

Full Text (PDF) - RSNA


Sep 2, 2010 ... Maude Labelle, MD. Mona M. El Khoury, MD ..... (54% vs 46%), and were more often high-grade .... in the series of Dent et al (29); and in the study by Dogan and ...... Bertos NR, Park M. Breast cancer: one term, many entities?